Abbott India · NSE: ABBOTINDIA · BSE: 500488
Q3 FY22 results · Oct–Dec 2021
Abbott India reported revenue from operations of ₹1,224.36 crore (up 11.8% from Q3 FY21) and net profit of ₹199.20 crore (up 12.5% from Q3 FY21) for Q3 FY22 (Oct–Dec 2021), on a standalone basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,224.36 | 1,095.37 | +11.8% | 1,222.06 | +0.2% |
| Other income | 18.74 | 15.01 | +24.9% | 18.21 | +2.9% |
| Total income | 1,243.10 | 1,110.38 | +12.0% | 1,240.27 | +0.2% |
| Profit before tax | 266.65 | 237.88 | +12.1% | 257.19 | +3.7% |
| Net profit for the period | 199.20 | 177.14 | +12.5% | 192.33 | +3.6% |
| EPS, basic (₹) | 93.74 | 83.36 | +12.5% | 90.51 | +3.6% |
| Net margin (%) | 16.3 | 16.2 | 15.7 |
Standalone
- Filed with BSE
- 09 Feb 2022, 15:10 IST
- Board meeting
- 09 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE